Jennison Associates LLC Pmv Pharmaceuticals, Inc. Transaction History

Jennison Associates LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$9.23 - $22.43 $2.8 Million - $6.81 Million	-303,641 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$14.86 - $23.55 $3.14 Million - $4.98 Million	-211,337 Reduced 41.04%	303,641 $6.32 Million
Q4 2021 Feb 08, 2022	BUY	$19.99 - $30.24 $3.22 Million - $4.87 Million	160,929 Added 45.45%	514,978 $11.9 Million
Q3 2021 Nov 09, 2021	SELL	$26.84 - $36.58 $110,124 - $150,087	-4,103 Reduced 1.15%	354,049 $10.6 Million
Q1 2021 May 11, 2021	BUY	$30.66 - $49.5 $6.43 Million - $10.4 Million	209,558 Added 141.03%	358,152 $11.8 Million
Q4 2020 Feb 05, 2021	SELL	$31.86 - $61.51 $44,795 - $86,483	-1,406 Reduced 0.94%	148,594 $9.14 Million
Q3 2020 Nov 04, 2020	BUY	$35.5 - $38.0 $5.33 Million - $5.7 Million	150,000 New	150,000 $5.33 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $68.9M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.